Epigallocatechin Gallate and Other Antural Compounds in HPV Infections
Status:
Active, not recruiting
Trial end date:
2024-07-15
Target enrollment:
Participant gender:
Summary
The investigators enroll patients with a PAP-test cytology reporting LSIL or ASCUS.
Pateitns undergo HPV-DNA test for screening. Patients are treated with Epigallocatechin
galalte, hyaluronic acid, folic acid and Vitamin B12 by oral route.
After three months of treatment PAP-test and HPV-DNA test will be repeated.